APO Research
Talk to an analyst

APO RESEARCH · REPORT

Drug Allergy Treatments and Drugs

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Drug Allergy Treatments and Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

26 December 2025199 pages

Choose your research edition.

Industry ResearchDrug Allergy Treatments and Drugs Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Drug Allergy Treatments and Drugs Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Drug Allergy Treatments and Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Drug Allergy Treatments and Drugs Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Drug Allergy Treatments and Drugs Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Drug Allergy Treatments and Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Drug Allergy Treatments and Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Drug Allergy Treatments and Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Drug Allergy Treatments and Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Drug Allergy Treatments and Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Drug Allergy Treatments and Drugs include AAFA, Allergan plc, Allergy Therapeutics, Circassia, HAL Allergy Group, Mayo Clinic, Stallergenes Greer, Sunovion Pharmaceuticals and GlaxoSmithKline plc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Drug Allergy Treatments and Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Drug Allergy Treatments and Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Drug Allergy Treatments and Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Drug Allergy Treatments and Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Drug Allergy Treatments and Drugs Segment by Company

AAFA

Allergan plc

Allergy Therapeutics

Circassia

HAL Allergy Group

Mayo Clinic

Stallergenes Greer

Sunovion Pharmaceuticals

GlaxoSmithKline plc

Teva Pharmaceutical Industries

Drug Allergy Treatments and Drugs Segment by Type

Insulin

Penicillin and Related Drugs

Sulfa Drugs

Chemotherapy Drugs

Iodine

Other

Drug Allergy Treatments and Drugs Segment by Application

Pharmaceutical & Biotechnology Companies

Diagnostic Laboratories

Hospitals

Research & Academic Laboratories

Drug Allergy Treatments and Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drug Allergy Treatments and Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Drug Allergy Treatments and Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drug Allergy Treatments and Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Drug Allergy Treatments and Drugs market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Drug Allergy Treatments and Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Drug Allergy Treatments and Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Drug Allergy Treatments and Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Drug Allergy Treatments and Drugs Industry Trends Table 2. Drug Allergy Treatments and Drugs Industry Drivers Table 3. Drug Allergy Treatments and Drugs Industry Opportunities and Challenges Table 4. Drug Allergy Treatments and Drugs Industry Restraints Table 5. Global Drug Allergy Treatments and Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Drug Allergy Treatments and Drugs Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Drug Allergy Treatments and Drugs Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Drug Allergy Treatments and Drugs Sales Market Share by Manufacturers Table 9. Global Drug Allergy Treatments and Drugs Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Drug Allergy Treatments and Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Drug Allergy Treatments and Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Drug Allergy Treatments and Drugs Manufacturers, Product Type & Application Table 13. Global Drug Allergy Treatments and Drugs Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Drug Allergy Treatments and Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Insulin Table 17. Major Manufacturers of Penicillin and Related Drugs Table 18. Major Manufacturers of Sulfa Drugs Table 19. Major Manufacturers of Chemotherapy Drugs Table 20. Major Manufacturers of Iodine Table 21. Major Manufacturers of Other Table 22. Global Drug Allergy Treatments and Drugs Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 23. Global Drug Allergy Treatments and Drugs Sales by Type (2021-2026) & (K Units) Table 24. Global Drug Allergy Treatments and Drugs Sales by Type (2027-2032) & (K Units) Table 25. Global Drug Allergy Treatments and Drugs Sales Market Share by Type (2021-2026) Table 26. Global Drug Allergy Treatments and Drugs Sales Market Share by Type (2027-2032) Table 27. Global Drug Allergy Treatments and Drugs Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 28. Global Drug Allergy Treatments and Drugs Revenue by Type (2021-2026) & (K Units) Table 29. Global Drug Allergy Treatments and Drugs Revenue by Type (2027-2032) & (K Units) Table 30. Global Drug Allergy Treatments and Drugs Revenue Market Share by Type (2021-2026) Table 31. Global Drug Allergy Treatments and Drugs Revenue Market Share by Type (2027-2032) Table 32. Major Manufacturers of Pharmaceutical & Biotechnology Companies Table 33. Major Manufacturers of Diagnostic Laboratories Table 34. Major Manufacturers of Hospitals Table 35. Major Manufacturers of Research & Academic Laboratories Table 36. Global Drug Allergy Treatments and Drugs Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Drug Allergy Treatments and Drugs Sales by Application (2021-2026) & (K Units) Table 38. Global Drug Allergy Treatments and Drugs Sales by Application (2027-2032) & (K Units) Table 39. Global Drug Allergy Treatments and Drugs Sales Market Share by Application (2021-2026) Table 40. Global Drug Allergy Treatments and Drugs Sales Market Share by Application (2027-2032) Table 41. Global Drug Allergy Treatments and Drugs Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 42. Global Drug Allergy Treatments and Drugs Revenue by Application (2021-2026) & (K Units) Table 43. Global Drug Allergy Treatments and Drugs Revenue by Application (2027-2032) & (K Units) Table 44. Global Drug Allergy Treatments and Drugs Revenue Market Share by Application (2021-2026) Table 45. Global Drug Allergy Treatments and Drugs Revenue Market Share by Application (2027-2032) Table 46. Global Drug Allergy Treatments and Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 47. Global Drug Allergy Treatments and Drugs Sales by Region (2021-2026) & (K Units) Table 48. Global Drug Allergy Treatments and Drugs Sales Market Share by Region (2021-2026) Table 49. Global Drug Allergy Treatments and Drugs Sales Forecasted by Region (2027-2032) & (K Units) Table 50. Global Drug Allergy Treatments and Drugs Sales Forecasted Market Share by Region (2027-2032) Table 51. North America Drug Allergy Treatments and Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. North America Drug Allergy Treatments and Drugs Sales by Country (2021-2026) & (K Units) Table 53. North America Drug Allergy Treatments and Drugs Sales by Country (2027-2032) & (K Units) Table 54. Europe Drug Allergy Treatments and Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Europe Drug Allergy Treatments and Drugs Sales by Country (2021-2026) & (K Units) Table 56. Europe Drug Allergy Treatments and Drugs Sales by Country (2027-2032) & (K Units) Table 57. Asia Pacific Drug Allergy Treatments and Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. Asia Pacific Drug Allergy Treatments and Drugs Sales by Country (2021-2026) & (K Units) Table 59. Asia Pacific Drug Allergy Treatments and Drugs Sales by Country (2027-2032) & (K Units) Table 60. South America, Middle East and Africa Drug Allergy Treatments and Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 61. South America, Middle East and Africa Drug Allergy Treatments and Drugs Sales by Country (2021-2026) & (K Units) Table 62. South America, Middle East and Africa Drug Allergy Treatments and Drugs Sales by Country (2027-2032) & (K Units) Table 63. Global Drug Allergy Treatments and Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 64. Global Drug Allergy Treatments and Drugs Revenue by Region (2021-2026) & (US$ Million) Table 65. Global Drug Allergy Treatments and Drugs Revenue by Region (2027-2032) & (US$ Million) Table 66. Global Drug Allergy Treatments and Drugs Revenue Market Share by Region (2021-2026) Table 67. Global Drug Allergy Treatments and Drugs Revenue Market Share by Region (2027-2032) Table 68. AAFA Company Information Table 69. AAFA Business Overview Table 70. AAFA Drug Allergy Treatments and Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. AAFA Drug Allergy Treatments and Drugs Product Portfolio Table 72. AAFA Recent Development Table 73. Allergan plc Company Information Table 74. Allergan plc Business Overview Table 75. Allergan plc Drug Allergy Treatments and Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Allergan plc Drug Allergy Treatments and Drugs Product Portfolio Table 77. Allergan plc Recent Development Table 78. Allergy Therapeutics Company Information Table 79. Allergy Therapeutics Business Overview Table 80. Allergy Therapeutics Drug Allergy Treatments and Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Allergy Therapeutics Drug Allergy Treatments and Drugs Product Portfolio Table 82. Allergy Therapeutics Recent Development Table 83. Circassia Company Information Table 84. Circassia Business Overview Table 85. Circassia Drug Allergy Treatments and Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Circassia Drug Allergy Treatments and Drugs Product Portfolio Table 87. Circassia Recent Development Table 88. HAL Allergy Group Company Information Table 89. HAL Allergy Group Business Overview Table 90. HAL Allergy Group Drug Allergy Treatments and Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. HAL Allergy Group Drug Allergy Treatments and Drugs Product Portfolio Table 92. HAL Allergy Group Recent Development Table 93. Mayo Clinic Company Information Table 94. Mayo Clinic Business Overview Table 95. Mayo Clinic Drug Allergy Treatments and Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Mayo Clinic Drug Allergy Treatments and Drugs Product Portfolio Table 97. Mayo Clinic Recent Development Table 98. Stallergenes Greer Company Information Table 99. Stallergenes Greer Business Overview Table 100. Stallergenes Greer Drug Allergy Treatments and Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Stallergenes Greer Drug Allergy Treatments and Drugs Product Portfolio Table 102. Stallergenes Greer Recent Development Table 103. Sunovion Pharmaceuticals Company Information Table 104. Sunovion Pharmaceuticals Business Overview Table 105. Sunovion Pharmaceuticals Drug Allergy Treatments and Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Sunovion Pharmaceuticals Drug Allergy Treatments and Drugs Product Portfolio Table 107. Sunovion Pharmaceuticals Recent Development Table 108. GlaxoSmithKline plc Company Information Table 109. GlaxoSmithKline plc Business Overview Table 110. GlaxoSmithKline plc Drug Allergy Treatments and Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. GlaxoSmithKline plc Drug Allergy Treatments and Drugs Product Portfolio Table 112. GlaxoSmithKline plc Recent Development Table 113. Teva Pharmaceutical Industries Company Information Table 114. Teva Pharmaceutical Industries Business Overview Table 115. Teva Pharmaceutical Industries Drug Allergy Treatments and Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Teva Pharmaceutical Industries Drug Allergy Treatments and Drugs Product Portfolio Table 117. Teva Pharmaceutical Industries Recent Development Table 118. Key Raw Materials Table 119. Raw Materials Key Suppliers Table 120. Drug Allergy Treatments and Drugs Distributors List Table 121. Drug Allergy Treatments and Drugs Customers List Table 122. Research Programs/Design for This Report Table 123. Authors List of This Report Table 124. Secondary Sources Table 125. Primary Sources List of Figures Figure 1. Drug Allergy Treatments and Drugs Product Image Figure 2. Global Drug Allergy Treatments and Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Drug Allergy Treatments and Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Drug Allergy Treatments and Drugs Sales (2021-2032) & (K Units) Figure 5. Global Drug Allergy Treatments and Drugs Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Drug Allergy Treatments and Drugs Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Insulin Image Figure 9. Penicillin and Related Drugs Image Figure 10. Sulfa Drugs Image Figure 11. Chemotherapy Drugs Image Figure 12. Iodine Image Figure 13. Other Image Figure 14. Global Drug Allergy Treatments and Drugs Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Drug Allergy Treatments and Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 16. Global Drug Allergy Treatments and Drugs Sales Market Share by Type (2021-2032) Figure 17. Global Drug Allergy Treatments and Drugs Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 18. Global Drug Allergy Treatments and Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Drug Allergy Treatments and Drugs Revenue Market Share by Type (2021-2032) Figure 20. Pharmaceutical & Biotechnology Companies Image Figure 21. Diagnostic Laboratories Image Figure 22. Hospitals Image Figure 23. Research & Academic Laboratories Image Figure 24. Global Drug Allergy Treatments and Drugs Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 25. Global Drug Allergy Treatments and Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 26. Global Drug Allergy Treatments and Drugs Sales Market Share by Application (2021-2032) Figure 27. Global Drug Allergy Treatments and Drugs Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 28. Global Drug Allergy Treatments and Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 29. Global Drug Allergy Treatments and Drugs Revenue Market Share by Application (2021-2032) Figure 30. North America Drug Allergy Treatments and Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 31. North America Drug Allergy Treatments and Drugs Sales Market Share by Country (2021-2032) Figure 32. U.S. Drug Allergy Treatments and Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Canada Drug Allergy Treatments and Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Mexico Drug Allergy Treatments and Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Europe Drug Allergy Treatments and Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Europe Drug Allergy Treatments and Drugs Sales Market Share by Country (2021-2032) Figure 37. Germany Drug Allergy Treatments and Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 38. France Drug Allergy Treatments and Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 39. U.K. Drug Allergy Treatments and Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Italy Drug Allergy Treatments and Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Netherlands Drug Allergy Treatments and Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Asia Pacific Drug Allergy Treatments and Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Asia Pacific Drug Allergy Treatments and Drugs Sales Market Share by Country (2021-2032) Figure 44. China Drug Allergy Treatments and Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Japan Drug Allergy Treatments and Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South Korea Drug Allergy Treatments and Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 47. Southeast Asia Drug Allergy Treatments and Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 48. India Drug Allergy Treatments and Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Australia Drug Allergy Treatments and Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South America, Middle East and Africa Drug Allergy Treatments and Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 51. South America, Middle East and Africa Drug Allergy Treatments and Drugs Sales Market Share by Country (2021-2032) Figure 52. Brazil Drug Allergy Treatments and Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 53. South Africa Drug Allergy Treatments and Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Saudi Arabia Drug Allergy Treatments and Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Turkey Drug Allergy Treatments and Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Argentina Drug Allergy Treatments and Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 57. UAE Drug Allergy Treatments and Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 58. Egypt Drug Allergy Treatments and Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 59. Chile Drug Allergy Treatments and Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 60. Global Drug Allergy Treatments and Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 61. Global Drug Allergy Treatments and Drugs Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 62. North America Drug Allergy Treatments and Drugs Revenue (2021-2032) & (US$ Million) Figure 63. North America Drug Allergy Treatments and Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Europe Drug Allergy Treatments and Drugs Revenue (2021-2032) & (US$ Million) Figure 65. Europe Drug Allergy Treatments and Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Asia-Pacific Drug Allergy Treatments and Drugs Revenue (2021-2032) & (US$ Million) Figure 67. Asia-Pacific Drug Allergy Treatments and Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. South America, Middle East and Africa Drug Allergy Treatments and Drugs Revenue (2021-2032) & (US$ Million) Figure 69. South America, Middle East and Africa Drug Allergy Treatments and Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 70. Drug Allergy Treatments and Drugs Value Chain Figure 71. Manufacturing Cost Structure Figure 72. Drug Allergy Treatments and Drugs Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Insulin
  • Penicillin and Related Drugs
  • Sulfa Drugs
  • Chemotherapy Drugs
  • Iodine
  • Other
Applications
  • Pharmaceutical & Biotechnology Companies
  • Diagnostic Laboratories
  • Hospitals
  • Research & Academic Laboratories
Companies covered
  • AAFA
  • Allergan plc
  • Allergy Therapeutics
  • Circassia
  • HAL Allergy Group
  • Mayo Clinic
  • Stallergenes Greer
  • Sunovion Pharmaceuticals
  • GlaxoSmithKline plc
  • Teva Pharmaceutical Industries

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Drug Allergy Treatments and Drugs Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Drug Allergy Treatments and Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Drug Allergy Treatments and Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Drug Allergy Treatments and Drugs Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Drug Allergy Treatments and Drugs Market Dynamics
  1. 2.1 Drug Allergy Treatments and Drugs Industry Trends
  2. 2.2 Drug Allergy Treatments and Drugs Industry Drivers
  3. 2.3 Drug Allergy Treatments and Drugs Industry Opportunities and Challenges
  4. 2.4 Drug Allergy Treatments and Drugs Industry Restraints
3 Drug Allergy Treatments and Drugs Market by Manufacturers
  1. 3.1 Global Drug Allergy Treatments and Drugs Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Drug Allergy Treatments and Drugs Sales by Manufacturers (2021-2026)
  3. 3.3 Global Drug Allergy Treatments and Drugs Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Drug Allergy Treatments and Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Drug Allergy Treatments and Drugs Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Drug Allergy Treatments and Drugs Manufacturers, Product Type & Application
  7. 3.7 Global Drug Allergy Treatments and Drugs Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Drug Allergy Treatments and Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Drug Allergy Treatments and Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Drug Allergy Treatments and Drugs Tier 1, Tier 2, and Tier 3
4 Drug Allergy Treatments and Drugs Market by Type
  1. 4.1 Drug Allergy Treatments and Drugs Type Introduction
  2. 4.1.1 Insulin
  3. 4.1.2 Penicillin and Related Drugs
  4. 4.1.3 Sulfa Drugs
  5. 4.1.4 Chemotherapy Drugs
  6. 4.1.5 Iodine
  7. 4.1.6 Other
  8. 4.2 Global Drug Allergy Treatments and Drugs Sales by Type
  9. 4.2.1 Global Drug Allergy Treatments and Drugs Sales by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Drug Allergy Treatments and Drugs Sales by Type (2021-2032)
  11. 4.2.3 Global Drug Allergy Treatments and Drugs Sales Market Share by Type (2021-2032)
  12. 4.3 Global Drug Allergy Treatments and Drugs Revenue by Type
  13. 4.3.1 Global Drug Allergy Treatments and Drugs Revenue by Type (2021 VS 2025 VS 2032)
  14. 4.3.2 Global Drug Allergy Treatments and Drugs Revenue by Type (2021-2032)
  15. 4.3.3 Global Drug Allergy Treatments and Drugs Revenue Market Share by Type (2021-2032)
5 Drug Allergy Treatments and Drugs Market by Application
  1. 5.1 Drug Allergy Treatments and Drugs Application Introduction
  2. 5.1.1 Pharmaceutical & Biotechnology Companies
  3. 5.1.2 Diagnostic Laboratories
  4. 5.1.3 Hospitals
  5. 5.1.4 Research & Academic Laboratories
  6. 5.2 Global Drug Allergy Treatments and Drugs Sales by Application
  7. 5.2.1 Global Drug Allergy Treatments and Drugs Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Drug Allergy Treatments and Drugs Sales by Application (2021-2032)
  9. 5.2.3 Global Drug Allergy Treatments and Drugs Sales Market Share by Application (2021-2032)
  10. 5.3 Global Drug Allergy Treatments and Drugs Revenue by Application
  11. 5.3.1 Global Drug Allergy Treatments and Drugs Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Drug Allergy Treatments and Drugs Revenue by Application (2021-2032)
  13. 5.3.3 Global Drug Allergy Treatments and Drugs Revenue Market Share by Application (2021-2032)
6 Global Drug Allergy Treatments and Drugs Sales by Region
  1. 6.1 Global Drug Allergy Treatments and Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Drug Allergy Treatments and Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Drug Allergy Treatments and Drugs Sales by Region (2021-2026)
  4. 6.2.2 Global Drug Allergy Treatments and Drugs Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Drug Allergy Treatments and Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Drug Allergy Treatments and Drugs Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Drug Allergy Treatments and Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Drug Allergy Treatments and Drugs Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Drug Allergy Treatments and Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Drug Allergy Treatments and Drugs Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Drug Allergy Treatments and Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Drug Allergy Treatments and Drugs Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Drug Allergy Treatments and Drugs Revenue by Region
  1. 7.1 Global Drug Allergy Treatments and Drugs Revenue by Region
  2. 7.1.1 Global Drug Allergy Treatments and Drugs Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Drug Allergy Treatments and Drugs Revenue by Region (2021-2026)
  4. 7.1.3 Global Drug Allergy Treatments and Drugs Revenue by Region (2027-2032)
  5. 7.1.4 Global Drug Allergy Treatments and Drugs Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Drug Allergy Treatments and Drugs Revenue (2021-2032)
  8. 7.2.2 North America Drug Allergy Treatments and Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Drug Allergy Treatments and Drugs Revenue (2021-2032)
  11. 7.3.2 Europe Drug Allergy Treatments and Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Drug Allergy Treatments and Drugs Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Drug Allergy Treatments and Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Drug Allergy Treatments and Drugs Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Drug Allergy Treatments and Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 AAFA
  2. 8.1.1 AAFA Company Information
  3. 8.1.2 AAFA Business Overview
  4. 8.1.3 AAFA Drug Allergy Treatments and Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 AAFA Drug Allergy Treatments and Drugs Product Portfolio
  6. 8.1.5 AAFA Recent Developments
  7. 8.2 Allergan plc
  8. 8.2.1 Allergan plc Company Information
  9. 8.2.2 Allergan plc Business Overview
  10. 8.2.3 Allergan plc Drug Allergy Treatments and Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Allergan plc Drug Allergy Treatments and Drugs Product Portfolio
  12. 8.2.5 Allergan plc Recent Developments
  13. 8.3 Allergy Therapeutics
  14. 8.3.1 Allergy Therapeutics Company Information
  15. 8.3.2 Allergy Therapeutics Business Overview
  16. 8.3.3 Allergy Therapeutics Drug Allergy Treatments and Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Allergy Therapeutics Drug Allergy Treatments and Drugs Product Portfolio
  18. 8.3.5 Allergy Therapeutics Recent Developments
  19. 8.4 Circassia
  20. 8.4.1 Circassia Company Information
  21. 8.4.2 Circassia Business Overview
  22. 8.4.3 Circassia Drug Allergy Treatments and Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Circassia Drug Allergy Treatments and Drugs Product Portfolio
  24. 8.4.5 Circassia Recent Developments
  25. 8.5 HAL Allergy Group
  26. 8.5.1 HAL Allergy Group Company Information
  27. 8.5.2 HAL Allergy Group Business Overview
  28. 8.5.3 HAL Allergy Group Drug Allergy Treatments and Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 HAL Allergy Group Drug Allergy Treatments and Drugs Product Portfolio
  30. 8.5.5 HAL Allergy Group Recent Developments
  31. 8.6 Mayo Clinic
  32. 8.6.1 Mayo Clinic Company Information
  33. 8.6.2 Mayo Clinic Business Overview
  34. 8.6.3 Mayo Clinic Drug Allergy Treatments and Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Mayo Clinic Drug Allergy Treatments and Drugs Product Portfolio
  36. 8.6.5 Mayo Clinic Recent Developments
  37. 8.7 Stallergenes Greer
  38. 8.7.1 Stallergenes Greer Company Information
  39. 8.7.2 Stallergenes Greer Business Overview
  40. 8.7.3 Stallergenes Greer Drug Allergy Treatments and Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Stallergenes Greer Drug Allergy Treatments and Drugs Product Portfolio
  42. 8.7.5 Stallergenes Greer Recent Developments
  43. 8.8 Sunovion Pharmaceuticals
  44. 8.8.1 Sunovion Pharmaceuticals Company Information
  45. 8.8.2 Sunovion Pharmaceuticals Business Overview
  46. 8.8.3 Sunovion Pharmaceuticals Drug Allergy Treatments and Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Sunovion Pharmaceuticals Drug Allergy Treatments and Drugs Product Portfolio
  48. 8.8.5 Sunovion Pharmaceuticals Recent Developments
  49. 8.9 GlaxoSmithKline plc
  50. 8.9.1 GlaxoSmithKline plc Company Information
  51. 8.9.2 GlaxoSmithKline plc Business Overview
  52. 8.9.3 GlaxoSmithKline plc Drug Allergy Treatments and Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 GlaxoSmithKline plc Drug Allergy Treatments and Drugs Product Portfolio
  54. 8.9.5 GlaxoSmithKline plc Recent Developments
  55. 8.10 Teva Pharmaceutical Industries
  56. 8.10.1 Teva Pharmaceutical Industries Company Information
  57. 8.10.2 Teva Pharmaceutical Industries Business Overview
  58. 8.10.3 Teva Pharmaceutical Industries Drug Allergy Treatments and Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Teva Pharmaceutical Industries Drug Allergy Treatments and Drugs Product Portfolio
  60. 8.10.5 Teva Pharmaceutical Industries Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Drug Allergy Treatments and Drugs Value Chain Analysis
  2. 9.1.1 Drug Allergy Treatments and Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Drug Allergy Treatments and Drugs Production Mode & Process
  6. 9.2 Drug Allergy Treatments and Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Drug Allergy Treatments and Drugs Distributors
  9. 9.2.3 Drug Allergy Treatments and Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst